A 2020 review on the safety of BPC-157 in preclinical (animal) studies states that the peptide did not show any test-related effects in the single-dose toxicity study and that it was well tolerated in repeat-dose evaluations.16 Other animal studies and reviews mention that BPC-157 has no reported toxicity or that it was without a lethal dose in toxicology studies.14 17 Even the authors of a small human study on BPC-157 for interstitial cystitis note that no one dropped out of the study, and no adverse events were reported.18 We want to highlight that most of the relevant studies have been conducted on animals, and more human research is needed
Prescription medications are provided only after consultation with a physician to determine if the medication is appropriate for you
ALP: Normal is 44-147 U/L
If the choice is between oral BPC-157 and no BPC-157 at all, the oral version provides at least some exposure to the peptide
Gut issues, including leaky gut, inflammatory bowel, IBS, Crohns, and diverticulitis
(7) Tesamorelin & CJC-1295 (Mod GRF 1-29) & Ipamorelin Blend and the GI Tract Ipamorelin is believed to primarily interact with the ghrelin receptor within the GI tract
